Abivax SA (ABVX), a clinical-stage biotechnology company, Thursday said that it has priced its public offering of 10.16 million American Depositary Shares (ADSs) at $64 per ADS.
The offering price of ADS, each representing one ordinary share, is equal to the volume weighted average price of the ordinary shares over the last 3 trading sessions preceding the pricing of the offering, plus a 21% premium.
Leerink Partners, Piper Sandler & Co. and Guggenheim Securities are acting as joint bookrunning managers for the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.